Le Chat

Founded in 2023 by Arthur Mensch, Timothée Lacroix, and Guillaume Lample (former researchers at Meta and DeepMind), Mistral AI is Europe's most highly valued AI startup: €11.7 billion (Series C, September 2025, led by ASML).

The company targets €1 billion in revenue by 2026, is investing €1.2 billion in a data center in Sweden, and building a compute center with 18,000 NVIDIA Grace Blackwell Superchips in Essonne (France). Its partners include BNP Paribas, the French military, France Travail, and the government of Luxembourg.

For healthcare institutions, the fact that Mistral AI is a French company, subject to European law and the GDPR, is a structuring argument — even if the question of legal neutrality cannot be reduced to the publisher's nationality alone.

Le Chat is Mistral AI's consumer-facing interface. It works like ChatGPT — you ask a question, it answers — but with notable differences in terms of sovereignty, native multilingualism, and deployment flexibility.

Le Chat stands out through its native multilingual reasoning: it can reason directly in French, Spanish, Japanese, and other languages, without going through English as an intermediary step — an advantage for linguistic precision in francophone clinical contexts.

This is Le Chat's main differentiator for healthcare professionals.

Le Chat represents the most credible option for European healthcare institutions that want to use an LLM without sending data to the United States. The sovereignty argument is real: French publisher, EU hosting, on-premise deployment available.

The quality of Mistral Large 3 has considerably closed the gap with leading American models. For common professional uses — writing assistance, summarization, literature review — the performance gap is no longer prohibitive.

Le Chat Enterprise opens concrete scenarios for institutions: a hospital or care network can deploy Le Chat on its own infrastructure, integrate it with its document management tools (SharePoint, Drive), and have teams work with an AI assistant with no risk of data leakage outside the organization.

For individual clinicians, the calculation is different. The free version of Le Chat is a reasonable alternative to ChatGPT for non-clinical uses. But for any use involving patient data — even anonymized — only the Enterprise version with controlled deployment provides the necessary guarantees. And as with any LLM, the HAS A.V.E.C. framework fully applies.

Mistral also publishes open-weight models under the Apache 2.0 license that can be installed locally, with no dependency on Mistral AI. See our dedicated model card.